Toggle navigation
Home
Search
Services
Blog
Contact
About
Screening Assay for Anticancer and Antiviral Drugs
Watson, Julia C.
Ribogene, Inc., Hayward, CA, United States
Search 4 grants from Julia Watson
Search grants from Ribogene, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Visualizing tumor heterogeneity in an immune intact and autochthonous mouse model of breast cancer
Race/Ethnicity and Mammographic Density: Genetic and Lifestyle Factors
Acquiring language with a cochlear implant: The role of sequential learning
Biomarkers Core
Acquisition of a Hybridoma Facility
Recently added grants:
Forum on Microbial Threats
Functional analysis of a Group A streptococcal locus important for fitness in soft tissue
Administrative Core
Human Subjects Core
Dynamical modeling of hospital transmission and antibiotic resistance evolution in a multidrug resistant nosocomial pathogen
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA065331-02A1
Application #
2008636
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Project Start
1996-09-30
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Ribogene, Inc.
Department
Type
DUNS #
City
Hayward
State
CA
Country
United States
Zip Code
94545
Related projects
NIH 1997
R44 CA
Screening Assay for Anticancer and Antiviral Drugs
Watson, Julia C. / Ribogene, Inc.
NIH 1996
R44 CA
Screening Assay for Anticancer and Antiviral Drugs
Watson, Julia C. / Ribogene, Inc.
Comments
Be the first to comment on Julia Watson's grant